Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 348.41M | 353.79M | 345.93M | 335.85M | 329.36M | 381.61M |
Gross Profit | 126.07M | 132.65M | 128.13M | 122.40M | 123.54M | 138.06M |
EBITDA | 63.67M | -22.36M | 76.87M | 54.38M | 42.59M | 61.12M |
Net Income | -80.05M | -189.70M | -72.30M | -79.62M | -85.18M | -75.81M |
Balance Sheet | ||||||
Total Assets | 1.76B | 1.95B | 2.15B | 2.18B | 2.21B | 2.29B |
Cash, Cash Equivalents and Short-Term Investments | 47.12M | 21.65M | 46.41M | 53.65M | 59.74M | 72.36M |
Total Debt | 1.04B | 1.15B | 1.18B | 1.12B | 1.09B | 1.23B |
Total Liabilities | 1.11B | 1.26B | 1.24B | 1.18B | 1.17B | 1.33B |
Stockholders Equity | 647.03M | 684.56M | 894.15M | 992.64M | 1.03B | 956.99M |
Cash Flow | ||||||
Free Cash Flow | -125.07M | -101.75M | -773.00K | 302.00K | 19.81M | 19.91M |
Operating Cash Flow | -101.96M | -79.85M | 21.62M | 28.30M | 38.88M | 41.81M |
Investing Cash Flow | 155.69M | 63.97M | -62.82M | -41.78M | -47.92M | -82.49M |
Financing Cash Flow | -31.54M | -1.35M | 55.97M | 4.64M | 4.08M | 19.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $154.09M | 19.72 | 51.91% | 4.64% | 24.72% | 30.05% | |
64 Neutral | $552.97M | 112.93 | 1.94% | 10.26% | 0.90% | ― | |
63 Neutral | $7.09B | 13.59 | -0.39% | 6.85% | 4.08% | -25.24% | |
63 Neutral | $573.83M | 31.96 | 10.08% | 7.11% | 0.14% | -0.76% | |
59 Neutral | $994.63M | ― | -14.32% | 0.97% | 4.29% | 18.89% | |
54 Neutral | $444.22M | ― | -2.22% | 11.97% | 2.96% | -877.53% | |
40 Neutral | $204.87M | ― | -11.41% | ― | -0.99% | 49.89% |
On May 22, 2025, National Healthcare Properties, Inc. held its annual meeting where stockholders approved the 2025 Omnibus Incentive Compensation Plan. This plan allows directors and employees to participate, with a total of 1,900,000 shares available for issuance, plus an additional 6.5% of shares from future offerings until the initial public offering. The plan will expire on May 22, 2035. Additionally, stockholders re-elected directors and ratified PricewaterhouseCoopers LLP as the independent accounting firm for 2025.